195 related articles for article (PubMed ID: 14981238)
41. An allosteric modulator binds to a conformational hub in the β
Liu X; Kaindl J; Korczynska M; Stößel A; Dengler D; Stanek M; Hübner H; Clark MJ; Mahoney J; Matt RA; Xu X; Hirata K; Shoichet BK; Sunahara RK; Kobilka BK; Gmeiner P
Nat Chem Biol; 2020 Jul; 16(7):749-755. PubMed ID: 32483378
[TBL] [Abstract][Full Text] [Related]
42. Plasmon-waveguide resonance studies of ligand binding to the human beta 2-adrenergic receptor.
Devanathan S; Yao Z; Salamon Z; Kobilka B; Tollin G
Biochemistry; 2004 Mar; 43(11):3280-8. PubMed ID: 15023079
[TBL] [Abstract][Full Text] [Related]
43. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor.
Yao X; Parnot C; Deupi X; Ratnala VR; Swaminath G; Farrens D; Kobilka B
Nat Chem Biol; 2006 Aug; 2(8):417-22. PubMed ID: 16799554
[TBL] [Abstract][Full Text] [Related]
44. The Principles of Ligand Specificity on beta-2-adrenergic receptor.
Chan HC; Filipek S; Yuan S
Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221
[TBL] [Abstract][Full Text] [Related]
45. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
46. Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias.
Stanek M; Picard LP; Schmidt MF; Kaindl JM; Hübner H; Bouvier M; Weikert D; Gmeiner P
J Med Chem; 2019 May; 62(10):5111-5131. PubMed ID: 31042379
[TBL] [Abstract][Full Text] [Related]
47. Function-specific virtual screening for GPCR ligands using a combined scoring method.
Kooistra AJ; Vischer HF; McNaught-Flores D; Leurs R; de Esch IJ; de Graaf C
Sci Rep; 2016 Jun; 6():28288. PubMed ID: 27339552
[TBL] [Abstract][Full Text] [Related]
48. Examination of ligand-induced conformational changes in the beta 2-adrenergic receptor by fluorescence spectroscopy.
Kobilka BK; Gether U
Adv Pharmacol; 1998; 42():470-3. PubMed ID: 9327941
[No Abstract] [Full Text] [Related]
49. Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
Blin N; Camoin L; Maigret B; Strosberg AD
Mol Pharmacol; 1993 Dec; 44(6):1094-104. PubMed ID: 7903415
[TBL] [Abstract][Full Text] [Related]
50. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
51. Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases.
Xiao RP; Tomhave ED; Wang DJ; Ji X; Boluyt MO; Cheng H; Lakatta EG; Koch WJ
J Clin Invest; 1998 Mar; 101(6):1273-82. PubMed ID: 9502768
[TBL] [Abstract][Full Text] [Related]
52. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor.
Ghanouni P; Steenhuis JJ; Farrens DL; Kobilka BK
Proc Natl Acad Sci U S A; 2001 May; 98(11):5997-6002. PubMed ID: 11353823
[TBL] [Abstract][Full Text] [Related]
53. Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor.
Zocher M; Fung JJ; Kobilka BK; Müller DJ
Structure; 2012 Aug; 20(8):1391-402. PubMed ID: 22748765
[TBL] [Abstract][Full Text] [Related]
54. Norepinephrine- and epinephrine-induced distinct beta2-adrenoceptor signaling is dictated by GRK2 phosphorylation in cardiomyocytes.
Wang Y; De Arcangelis V; Gao X; Ramani B; Jung YS; Xiang Y
J Biol Chem; 2008 Jan; 283(4):1799-807. PubMed ID: 18056263
[TBL] [Abstract][Full Text] [Related]
55. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor.
Ghanouni P; Gryczynski Z; Steenhuis JJ; Lee TW; Farrens DL; Lakowicz JR; Kobilka BK
J Biol Chem; 2001 Jul; 276(27):24433-6. PubMed ID: 11320077
[TBL] [Abstract][Full Text] [Related]
56. Functional alpha1- and beta2-adrenergic receptors in human osteoblasts.
Huang HH; Brennan TC; Muir MM; Mason RS
J Cell Physiol; 2009 Jul; 220(1):267-75. PubMed ID: 19334040
[TBL] [Abstract][Full Text] [Related]
57. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
58. Site-directed mutagenesis of the human beta3-adrenoceptor--transmembrane residues involved in ligand binding and signal transduction.
Gros J; Manning BS; Pietri-Rouxel F; Guillaume JL; Drumare MF; Strosberg AD
Eur J Biochem; 1998 Feb; 251(3):590-6. PubMed ID: 9490030
[TBL] [Abstract][Full Text] [Related]
59. Profile of ligand binding to the porcine beta2-adrenergic receptor.
Liang W; Mills S
J Anim Sci; 2001 Apr; 79(4):877-83. PubMed ID: 11325192
[TBL] [Abstract][Full Text] [Related]
60. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics.
Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA
Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
